|
1
|
Rahimov F, Jugessur A and Murray JC:
Genetics of nonsyndromic orofacial clefts. Cleft Palate Craniofac
J. 49:73–91. 2012. View
Article : Google Scholar :
|
|
2
|
Vieira AR: Unraveling human cleft lip and
palate research. J Dent Res. 87:119–125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sitzman TJ and Marcus JR: Cleft lip and
palate: Current surgical management. Clin Plast Surg. 41:xi–xii.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Noorollahian M, Nematy M, Dolatian A,
Ghesmati H, Akhlaghi S and Khademi GR: Cleft lip and palate and
related factors: A 10 years study in university hospitalised
patients at Mashhad-Iran. Afr J Paediatr Surg. 12:286–290. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuchler EC, Silva LAD, Nelson-Filho P,
Sabóia TM, Rentschler AM, Granjeiro JM, Oliveira D, Tannure PN,
Silva RAD, Antunes LS, et al: Assessing the association between
hypoxia during craniofacial development and oral clefts. J Appl
Oral Sci. 26. pp. e201702342018, View Article : Google Scholar
|
|
6
|
Mulliken JB and Kim DC: Repair of
bilateral incomplete cleft lip: Techniques and outcomes. Plast
Reconstr Surg. 132:923–932. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen J, Shen W and Cui J: Modification of
the rotation-advancement principle in cleft lip repair. J Craniofac
Surg. 20:2215–2216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Shen W and Cui J: A marking for
moderate bilateral cleft lip. J Craniofac Surg. 26:2022–2023. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Shen W and Jie C: Mild incomplete
cleft lip repair. J Craniofac Surg. 23:1131–1132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jianbing C, Shen W and Cui J: A marking
for repair of complete cleft lip. J Craniofac Surg. 25:1122–1124.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumari P, Singh SK and Raman R: A novel
non-coding RNA within an intron of CDH2 and association of its SNP
with non-syndromic cleft lip and palate. Gene. 658:123–128. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Zou J, Li Q, Chen L, Gao Y, Yan H,
Zhou B and Li J: Assessment of differentially expressed plasma
microRNAs in nonsyndromic cleft palate and nonsyndromic cleft lip
with cleft palate. Oncotarget. 7:86266–86279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mehrotra D: Genomic expression in non
syndromic cleft lip and palate patients: A review. J Oral Biol
Craniofac Res. 5:86–91. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou J, Li J, Li J, Ji C, Li Q and Guo X:
Expression profile of plasma microRNAs in nonsyndromic cleft lip
and their clinical significance as biomarkers. Biomed Pharmacother.
82:459–466. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng N, Ding X, Sun A and Jahan R: PDK1
activity regulates proliferation, invasion and growth of
hemangiomas. Cell Physiol Biochem. 36:1903–1910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Yang C, Zhang L and Yang P:
MicroRNA-210 induces endothelial cell apoptosis by directly
targeting PDK1 in the setting of atherosclerosis. Cell Mol Biol
Lett. 22:32017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang R, Bush JO and Lidral AC:
Development of the upper lip: Morphogenetic and molecular
mechanisms. Dev Dyn. 235:1152–1166. 2006. View Article : Google Scholar
|
|
21
|
Johnston MC and Bronsky PT: Prenatal
craniofacial development: New insights on normal and abnormal
mechanisms. Crit Rev Oral Biol Med. 6:25–79. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ray HJ and Niswander L: Mechanisms of
tissue fusion during development. Development. 139:1701–1711. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashique AM, Fu K and Richman JM:
Endogenous bone morphogenetic proteins regulate outgrowth and
epithelial survival during avian lip fusion. Development.
129:4647–4660. 2002.PubMed/NCBI
|
|
24
|
Cox TC: Taking it to the max: The genetic
and developmental mechanisms coordinating midfacial morphogenesis
and dysmorphology. Clin Genet. 65:163–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun D, Baur S and Hay ED:
Epithelial-mesenchymal transformation is the mechanism for fusion
of the craniofacial primordia involved in morphogenesis of the
chicken lip. Dev Biol. 228:337–349. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Zhao J and Wang R: Biologic
characteristics and osteogenic differentiation of maxillary
primordium mesenchymal cells. J Craniofac Surg. 26:340–342. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li
JH, Xu XM, Liu S, Chen J, Liu F, et al: Phosphoinositide
3-kinase/Akt pathway plays an important role in chemoresistance of
gastric cancer cells against etoposide and doxorubicin induced cell
death. Int J Cancer. 122:433–443. 2008. View Article : Google Scholar
|
|
29
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M and
Moriyama M: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bush JO and Jiang R: Palatogenesis:
Morphogenetic and molecular mechanisms of secondary palate
development. Development. 139:231–243. 2012. View Article : Google Scholar :
|
|
31
|
Yu H, Ye X, Guo N and Nathans J: Frizzled
2 and frizzled 7 function redundantly in convergent extension and
closure of the ventricular septum and palate: Evidence for a
network of interacting genes. Development. 139:4383–4394. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lidral AC, Murray JC, Buetow KH, Basart
AM, Schearer H, Shiang R, Naval A, Layda E, Magee K and Magee W:
Studies of the candidate genes TGFB2, MSX1, TGFA, and TGFB3 in the
etiology of cleft lip and palate in the Philippines. Cleft Palate
Craniofac J. 34:1–6. 1997.PubMed/NCBI
|
|
33
|
Zhang Y, Li T, Qiu Y, Zhang T, Guo P, Ma
X, Wei Q and Han L: Serum microRNA panel for early diagnosis of the
onset of hepa-tocellular carcinoma. Medicine (Baltimore).
96:e56422017. View Article : Google Scholar
|
|
34
|
Keller A, Leidinger P, Steinmeyer F,
Stähler C, Franke A, Hemmrich-Stanisak G, Kappel A, Wright I, Dörr
J, Paul F, et al: Comprehensive analysis of microRNA profiles in
multiple sclerosis including next-generation sequencing. Mult
Scler. 20:295–303. 2014. View Article : Google Scholar
|
|
35
|
Gu Y, Zhang Y, Zhao C, Pan Y, Smales RJ,
Wang H, Ni Y, Zhang H, Ni J, Ma J and Wang L: Serum microRNAs as
potential biomarkers of mandibular prognathism. Oral Dis. 20:55–61.
2014. View Article : Google Scholar
|
|
36
|
Foda HD and Zucker S: Matrix
metalloproteinases in cancer invasion, metastasis and angiogenesis.
Drug Discov Today. 6:478–482. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Webb AH, Gao BT, Goldsmith ZK, Irvine AS,
Saleh N, Lee RP, Lendermon JB, Bheemreddy R, Zhang Q, Brennan RC,
et al: Inhibition of MMP-2 and MMP-9 decreases cellular migration,
and angiogenesis in in vitro models of retinoblastoma. BMC Cancer.
17:4342017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Westmoreland JJ, Wang Q, Bouzaffour M,
Baker SJ and Sosa-Pineda B: Pdk1 activity controls proliferation,
survival, and growth of developing pancreatic cells. Dev Biol.
334:285–298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wada M, Horinaka M, Yasuda S, Masuzawa M,
Sakai T and Katoh N: PDK1 is a potential therapeutic target against
angiosarcoma cells. J Dermatol Sci. 78:44–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gagliardi PA, di Blasio L and Primo L:
PDK1: A signaling hub for cell migration and tumor invasion.
Biochim Biophys Acta. 1856:178–188. 2015.PubMed/NCBI
|
|
41
|
Lawlor MA, Mora A, Ashby PR, Williams MR,
Murray-Tait V, Malone L, Prescott AR, Lucocq JM and Alessi DR:
Essential role of PDK1 in regulating cell size and development in
mice. EMBO J. 21:3728–3738. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xie F, Huang Q, Liu CH, Lin XS, Liu Z, Liu
LL, Huang DW and Zhou HC: miR-1271 negatively regulates AKT/MTOR
signaling and promotes apoptosis via targeting PDK1 in pancreatic
cancer. Eur Rev Med Pharmacol Sci. 22:678–686. 2018.PubMed/NCBI
|
|
43
|
Wang Z, Yao YJ, Zheng F, Guan Z, Zhang L,
Dong N and Qin WJ: Mir-138-5p acts as a tumor suppressor by
targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.
Eur Rev Med Pharmacol Sci. 21:5624–5629. 2017.PubMed/NCBI
|
|
44
|
Wang J, Yang S, Ge W, Wang Y, Han C and Li
M: miR-613 suppressed the laryngeal squamous cell carcinoma
progression through regulating PDK1. J Cell Biochem. 119:5118–5125.
2018. View Article : Google Scholar
|
|
45
|
Wang J and Sun X: MicroRNA-375 inhibits
the proliferation, migration and invasion of kidney cancer cells by
triggering apoptosis and modulation of PDK1 expression. Environ
Toxicol Pharmacol. 62:227–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Fu L, Cui M, Wang Y, Xu Y, Li M
and Mi J: Amino acid transporter SLC38A3 promotes metastasis of
non-small cell lung cancer cells by activating PDK1. Cancer Lett.
393:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sargeant AM, Klein RD, Rengel RC, Clinton
SK, Kulp SK, Kashida Y, Yamaguchi M, Wang X and Chen CS:
Chemopreventive and bioenergetic signaling effects of PDK1/Akt
pathway inhibition in a transgenic mouse model of prostate cancer.
Toxicol Pathol. 35:549–561. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mo Y, Lu Y, Wang P, Huang S, He L, Li D,
Li F, Huang J, Lin X, Li X, et al: Long non-coding RNA XIST
promotes cell growth by regulating miR-139-5p /PDK1/AKT axis in
hepatocellular carcinoma. Tumour Biol. 39:10104283176909992017.
View Article : Google Scholar
|
|
49
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jia S, Agarwal M, Yang J, Horowitz JC,
White ES and Kim KK: Discoidin domain receptor 2 signaling
regulates fibroblast apop-tosis through PDK1/Akt. Am J Respir Cell
Mol Biol. 59:295–305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Maga G and Hubscher U: Proliferating cell
nuclear antigen (PCNA): A dancer with many partners. J Cell Sci.
116:3051–3060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW
and Ho KY: The prognostic value of proliferating cell nuclear
antigen (PCNA) and p53 protein expression in patients with advanced
nasopharyngeal carcinoma. Acta Otolaryngol. 126:769–774. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dai B, Wu Q, Zeng C, Zhang J, Cao L, Xiao
Z and Yang M: The effect of Liuwei Dihuang decoction on PI3K/Akt
signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats
with insulin resistance. J Ethnopharmacol. 192:382–389. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nitulescu GM, Van De Venter M, Nitulescu
G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Grădinaru D, Tsatsakis
A, Tsoukalas D, et al: The Akt pathway in oncology therapy and
beyond (Review). Int J Oncol. 53:2319–2331. 2018.PubMed/NCBI
|
|
55
|
Xue M, Chen X, Guo Z, Liu X, Bi Y, Yin J,
Hu H, Zhu P, Zhuang J, Cates C, et al: L-Carnitine attenuates
cardiac dysfunction by ischemic insults through Akt signaling
pathway. Toxicol Sci. 160:4292017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Steelman LS, Martelli AM, Cocco L, Libra
M, Nicoletti F, Abrams SL and McCubrey JA: The therapeutic
potential of mTOR inhibitors in breast cancer. Br J Clin Pharmacol.
82:1189–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Donia M, Mangano K, Amoroso A, Mazzarino
MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P and Nicoletti F:
Treatment with rapamycin ameliorates clinical and histological
signs of protracted relapsing experimental allergic
encephalomyelitis in Dark Agouti rats and induces expansion of
peripheral CD4+CD25+Foxp3+
regulatory T cells. J Autoimmun. 33:135–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Nicoletti F, Lapenta C, Donati S, Spada M,
Ranazzi A, Cacopardo B, Mangano K, Belardelli F, Perno C and Aquaro
S: Inhibition of human immunodeficiency virus (HIV-1) infection in
human peripheral blood leucocytes-SCID reconstituted mice by
rapamycin. Clin Exp Immunol. 155:28–34. 2009. View Article : Google Scholar :
|
|
59
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kinoshita S, Ri M, Kanamori T, Aoki S,
Yoshida T, Narita T, Totani H, Ito A, Kusumoto S, Ishida T, et al:
Potent antitumor effect of combination therapy with sub-optimal
doses of Akt inhibitors and pomalidomide plus dexamethasone in
multiple myeloma. Oncol Lett. 15:9450–9456. 2018.PubMed/NCBI
|
|
61
|
Chang Z, Shi G, Jin J, Guo H, Guo X, Luo
F, Song Y and Jia X: Dual PI3K/mTOR inhibitor NVP-BEZ235-induced
apoptosis of hepatocellular carcinoma cell lines is enhanced by
inhibitors of autophagy. Int J Mol Med. 31:1449–1456. 2013.
View Article : Google Scholar : PubMed/NCBI
|
